Efficacy of Percutaneous Injection of Triamcinolone in the Treatment of Mammillary Fistula
Recruitment status was: Recruiting
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Efficacy of Percutaneous Injection of Triamcinolone in the Treatment of Mammillary Fistula|
- Resolution of mammillary fistula [ Time Frame: one year ] [ Designated as safety issue: No ]
|Study Start Date:||March 2011|
|Estimated Study Completion Date:||September 2012|
|Estimated Primary Completion Date:||March 2012 (Final data collection date for primary outcome measure)|
Percutaneous drainage and saline solution irrigation
Percutaneous drainage and saline solution irrigation plus percutaneous triamcinolone
To compare the results from a prospective observational database with two groups of patients:
- patients with MF treated by percutaneous drainage and saline solution.
- patients with MF treated by percutaneous drainage and saline solution plus percutaneous triamcinolone.
These patients are treated following usual clinical practice in our Department. All the procedures are made through an ultrasound-guided way. During the follow-up of these cases (clinical and with ultrasound) resolution rate will be registered by the same investigator.
The follow-up will be at least 6 months.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01315080
|Virgen de la Arrixaca University Hospital|
|Murcia, Spain, 30120|
|Principal Investigator:||Juan D Berna, MD PhD||Virgen de la Arrixaca University Hospital|